$1.5M sweet spot round size
Most of their 325 investments are in rounds between $12M and $45M
1999
Tentarix Biotherapeutics, Inc. raised $35M on September 6, 2023
Investors: Gilead Sciences, Amplitude Ventures, Samsara BioCapital and Versant Ventures
Kate Therapeutics raised $51M on June 8, 2023
Investors: UF Innovate | Ventures, Osage University Partners (OUP), Westlake Village BioPartners® and Versant Ventures
Belharra Therapeutics raised $50M on January 4, 2023
Investors: Versant Ventures
Undisclosed raised $30M on December 12, 2022
Investors: Black Diamond Therapeutics and Versant Ventures
iECURE, inc. raised $65M on November 30, 2022
Investors: LYFE Capital, OrbiMed Advisors, Novo Holdings and Versant Ventures
Jnana Therapeutics raised $107M on November 15, 2022
Investors: Avalon Venture, RA Capital Management, L.P., Polaris Partners and Versant Ventures
Vector BioPharma raised $30M on August 10, 2022
Investors: Versant Ventures
Tempest raised $15M on April 27, 2022
Investors: Versant Ventures
Cimeio Therapeutics raised $50M on April 13, 2022
Investors: Versant Ventures
Ventus Therapeutics raised $140M on February 9, 2022
Investors: Qatar Investment Authority, GV, RA Capital Management, L.P., Andreessen Horowitz, Casdin Capital, LLC, SoftBank Investment Advisers and Versant Ventures